Kierkethumbs up convincinglyOne thing I don’t understand about how Eli Lilly and Novo Nordisk are being valued is how their share price can drop like 15% if their research for their next glp-1 product says the average weight loss is like 25% instead of 27% …
…when Americans still buy the Chinese knock-offs from Hims and Hers with unclear effects
Kevin Karhan :verified:@Kierkegaanks@beige.party I think #ForProfitHealthcare should be outlawed.
Espechally the #US system where it's treated as a commodity similar to Cable TV and Fast Food, instead of a #HumanRight!
https://www.youtube.com/watch?v=wO1IoKN0AkY
https://www.youtube.com/watch?v=YKlcY3CWr5g
#Healthcare #USpol #USA
Kierkethumbs up convincingly@kkarhan@infosec.space to be clear, eli and novo are pharmaceutical companies, and not private health insurers or providers
Kevin Karhan :verified:@Kierkegaanks@beige.party Yes but #Regulation in terms of #PharmaceuticalPricing and #Advertising works, as #Europe shows.
They still make more than a healthy margin wothout ripping off patients!
As #public|ly traded #corporations, their only allegiance is to their shareholders.
Otherwise they'd be #cooperatives!